On Thursday, Following Stocks were among the “Top Gainers” In U.S. Stock Exchange: Omega Healthcare Investors (NYSE:OHI), Achillion Pharmaceuticals, (NASDAQ:ACHN), Sumitomo Mitsui Financial Grp, (NYSE:SMFG), Loews (NYSE:L)
Omega Healthcare Investors Inc (NYSE:OHI) and Aviv REIT, Inc. (AVIV) disclosed the completion of Omega’s acquisition of all of the outstanding shares of Aviv in a stock-for-stock merger, forming a combined company with equity market capitalization of approximately $7.8 billion and a total market capitalization of almost $11.1 billion. The combined company will be the premier publicly traded real estate investment trust (REIT) focused principally on skilled nursing facilities (SNFs), with a diversified portfolio of investments including over 900 properties located in 41 states and operated by 81 different operators.
Omega Healthcare Investors Inc (NYSE:OHI) enhanced 1.82%, and closed at $41.48. The company holds the market capitalization of $5.75 billion. For the last twelve months, the stock was able to keep return on equity at 16.00%, while return on assets at 5.80%, in response to its return on investment at 9.10%. Its 20-day moving average gained 4.70%, below 50-day moving average of 1.91%, above 200-day moving average of 10.40% from the latest market price of $41.48. The mean recommendation of analysts for this stock is 2.40. (Where 1=Buy, 5=Sale).
Omega Healthcare Investors Inc (OHI) is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. was founded in 1992 and is based in Maryland, United States.
Formerly On March 5, 2015 Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) unveiled financial results for the three and twelve months ended December 31, 2014.
For the three months ended December 31, 2014, the Company reported a net loss of $21.6 million, compared to a net loss of $13.4 million in the three months ended December 31, 2013. For the full year ended December 31, 2014, the Company’s net loss was $69.0 million, or $0.70 per share, compared to a net loss of $58.9 million for the year ended December 31, 2013, or $0.63 per share. Cash, cash equivalents, marketable securities, and interest and subscriptions receivable at December 31, 2014 were $159.2 million.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)’s shares picked up 1.80%, and closed at $10.19. The stock volatility for the week is 4.38%, while for the month remained 4.71%. The company holds consensus target price of $18.30.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -0.70 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained -11.10% and Annual EPS growth for the past 5 years is considered as 6.50%.
The mean recommendation of analysts for this stock is 2.40. (Where 1=Buy, 5=Sale).
Achillion Pharmaceuticals, Inc. (ACHN) a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on developing combination therapies for the treatment of chronic hepatitis C (HCV) infection and drug-resistant bacterial infections.
Sumitomo Mitsui Financial Grp, Inc. (ADR)(NYSE:SMFG) inclined 1.80%, and closed at $7.93. The company has the market capitalization of $55.26 billion. The beta value of the stock is 0.95. On the other hand the stock’s volatility for the week is 0.79%, and for the month is 1.00%. The stock’s price to book ratio is $0.77, however price to sale ratio is $1.52. Analyst’s mean recommendation regarding this stock is 1.00. (Where 1=Buy, 5=Sale).
Sumitomo Mitsui Financial Grp, Inc. (ADR) (SMFG) along with its subsidiaries, offers various banking and financial products and services in Japan, the Americas, Europe, the Middle East, Asia, and Oceania. It operates in four segments: Commercial Banking, Leasing, Securities, and Consumer Finance.
Loews Corporation (NYSE:L) rose 1.78%, and closed at $41.15. The stock has the beta value of 1.07, and its volatility for the week is 1.52%, while for the month it is 1.44%. The company has the market capitalization of $15.32 billion. The company holds the book value per share of 51.54, whereas cash per share is 0.98. Price to book ratio remained 0.80, while price to sale ratio is 1.07. Analysts mean recommendation for the stock is said to be 2.50 (where 1=Buy, 5=sale).
Loews Corporation (L) along with its subsidiaries works as a commercial property and casualty insurance company mostly in the United States. The company offers management and professional liability insurance and risk management services, and other specialized property and casualty coverages; commercial surety and fidelity bonds; and warranty and alternative risk services primarily for vehicles and portable electronic communication devices.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
